ID   BALL-2
AC   CVCL_B388
SY   B-cell Acute Lymphoblastic Leukemia-2
DR   Wikidata; Q54753114
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1650133;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=1650133).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
RX   PubMed=1650133; DOI=10.1002/ajh.2830370309;
RA   Kubonishi, Ichiro
RA   Daibata, Masanori
RA   Yano, Shoki
RA   Isobe, Masaharu
RA   Kurosawa, Nobuyuki
RA   Nagumo, Hideki
RA   Ogita, Zen-ichi
RA   Ohyashiki, Junko H.
RA   Toyama, Keisuke
RA   Miyoshi, Isao
RT   "Establishment of a new Epstein-Barr virus nuclear antigen-positive
RT   B-cell line, BALL-2, with t(8;14) (q24;q32) chromosome abnormality from
RT   B-cell acute lymphoblastic leukemia, L2.";
RL   Am. J. Hematol. 37:179-185(1991).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//